XML 54 R38.htm IDEA: XBRL DOCUMENT v3.25.0.1
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of assets and liabilities measured at fair value on a recurring basis
The following fair value hierarchy table presents the components and classification of the Company’s financial assets and liabilities measured at fair value on a recurring basis as of:
 December 31, 2024December 31, 2023
 (in millions)TotalLevel 1Level 2Level 3TotalLevel 1Level 2Level 3
Assets:        
Cash equivalents$567 $557 $10 $— $425 $417 $$— 
Restricted cash$20 $20 $— $— $15 $15 $— $— 
Foreign currency exchange contracts$10 $— $10 $— $$— $$— 
Liabilities:    
Acquisition-related contingent consideration$359 $— $— $359 $292 $— $— $292 
Cross-currency swaps$34 $— $34 $— $84 $— $84 $— 
Foreign currency exchange contracts$$— $$— $$— $$— 
Schedule of cross-currency swaps included in the consolidated balance sheets
The assets and liabilities associated with the Company’s cross-currency swaps as included in the Consolidated Balance Sheets as of December 31, 2024 and 2023 are as follows:
(in millions)20242023
Other non-current liabilities$(40)$(90)
Prepaid expenses and other current assets$$
Net fair value$(34)$(84)
The assets and liabilities associated with the Company’s foreign exchange contracts as included in the Consolidated Balance Sheets as of December 31, 2024 and 2023 are as follows:
(in millions)20242023
Accrued and other current liabilities$(5)$(6)
Prepaid expenses and other current assets$10 $
Net fair value$$(3)
Schedule of effect of hedging instruments on financial statements
The following table presents the effect of hedging instruments on the Consolidated Statements of Operations and Consolidated Statements of Comprehensive Loss for 2024 and 2023:
(in millions)20242023
Gain (loss) recognized in Other comprehensive loss$50 $(45)
Gain excluded from assessment of hedge effectiveness$13 $13 
Location of gain of excluded componentInterest Expense
Schedule of foreign exchange contracts on the consolidated statements of operations and consolidated statements of cash flows
The following table presents the effect of the Company’s foreign exchange contracts on the Consolidated Statements of Operations and the Consolidated Statements of Cash Flows for 2024 and 2023:
(in millions)20242023
Gain (loss) related to changes in fair value$$(5)
Gain related to settlements$$
Schedule of assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs
The following table presents a reconciliation of contingent consideration obligations measured on a recurring basis using significant unobservable inputs (Level 3) for the years 2024 and 2023:
(in millions)20242023
Beginning balance, January 1, $292 $241 
Adjustments to Acquisition-related contingent consideration:
Accretion for the time value of money$20 $19 
Fair value adjustments due to changes in estimates of other future payments(5)40 
Acquisition-related contingent consideration15 59 
Additions (Note 3)89 38 
Payments / Settlements(37)(46)
Ending balance, December 31,359 292 
Current portion49 39 
Non-current portion$310 $253